Cytokinetics Announces MYQORZO™ (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...

Cytokinetics, Incorporated: Cytokinetics Announces MYQORZO (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incor ...
Nature

How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease?

Although more-refined techniques based on nuclear magnetic resonance are available, quantitative echocardiography is currently the most frequently used means of evaluating abnormalities in left ...
Medscape

Electrical Muscle Stimulation Boosts Function in Severe HF

Adding neuromuscular electrical stimulation to physiotherapy boosts functional performance in hospitalized patients with ...
Healthline

Symptoms and Early Signs of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) thickens the left ventricle in your heart, which can make pumping blood harder and raise the risk of complications if untreated. HCM symptoms can be mild or absent ...